Replimune’s Drug for Advanced Skin Cancer Fails to Win FDA Nod Again

by | Apr 10, 2026 | Health

The U.S. Food and Drug Administration on Friday declined to approve Replimune’s drug for advanced ⁠skin cancer, citing insufficient data from studies, a letter from the…
Reuters Health Information

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments